Glucagon-like peptide 1 (GLP1) is an incretin that enhances the secretion of insulin to reduce blood glucose levels; during obesity, intestinal epithelial lymphocytes can sequester GLP1 to limit its bioavailability9. The gene discussed is GCG; the disease is obesity disorder.